Developing a simple blood test for early breast cancer detection using calcium-binding biomarkers.
No capital raise or buyback data
| Event | Type | Confidence | Impact | Date | Status |
|---|---|---|---|---|---|
| Enhanced BREASTESTplus launch (C+D density) Covers both Breast C and D density women (~50% of screened population). Following 800-patient study | commercial milestone | Confirmed | arrow_upwardHigh | 30 June 2026 | Upcoming |
Historical delivery and spending consistency — data is limited for recently added companies.
No cash flow data